Deep involvement in advisory work on diagnostics from our inception.
Torreya has been involved in work in medical diagnostics from its inception.
Our team has a strong network within the diagnostics sector, extensive knowledge of the diagnostics marketplace and a track record of successfully concluded transactions.
Across the globe, pressures on healthcare system costs have caused spending on prevention to rise disproportionately. For example, in the United States the Affordable Care Act provides a strong incentive for the greater use of diagnostics oriented at screening for disease by generally leaving such spend out of consumer deductibles.
Advances in medical technology have been dramatic and have led to substantial growth across the diagnostics sector—from traditional areas like histopathology and IVD tests to newer areas in molecular diagnostics, genome sequencing and various novel tests based upon microRNA, protein fragments and the like.
Torreya Partners work in diagnostics has been varied but has focused to a significant degree on financing and strategic transactions involving new technologies. We have also been extensively involved in efforts at facilitating commercialization of diagnostics technologies.